Energy-Efficient Geopolymer Composites Containing Phase-Change Materials-Comparison of Different Contents and Types.

The purpose of this study was to analyze the effects of phase-change components on the properties of geopolymer foams. Geopolymer foams are lightweight foamed geopolymers that are characterized by a high degree of porosity. Phase change materials, on the other hand, are compounds that, when added to a material, allow it to absorb, store, and then release large amounts of energy.

Evaluation of an Embedded Health Psychologist Intervention for Obstetric Patients With Adverse Childhood Experiences.

Background: Screening for adverse childhood experiences (ACEs) and resilience in pregnancy is a promising practice for mitigating ACEs-related health complications. Yet, the best follow-up for pregnant patients with high ACEs and/or low resilience has not been established.

Objective: This study evaluates referrals to and participation in an embedded health psychologist (EHP) intervention for pregnant patients with ACEs and/or low resilience.

Innovative strategies for effective paclitaxel delivery: Recent developments and prospects.

Purpose: Paclitaxel is an effective chemotherapeutic agent against a variety of cancer types. However, the clinical utility of paclitaxel is restricted by its poor solubility in water and high toxicity, resulting in low drug tolerance. These difficulties could be resolved by using suitable pharmacological carriers.

Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil.

Purpose: The systemic treatment options for metastatic colorectal cancer (mCRC) are unsatisfactory, and the disease recurs despite the use of numerous medications and their combinations. Trifluridine/Tipiracil is a relatively new drug used in refractory mCRC. Little is known about its real-world effectiveness and prognostic and predictive factors.

Current and promising treatment strategies in glioma.

Gliomas are the most common primary central nervous system tumors; despite recent advances in diagnosis and treatment, glioma patients generally have a poor prognosis. Hence there is a clear need for improved therapeutic options. In recent years, significant effort has been made to investigate immunotherapy and precision oncology approaches.